Solventum (SOLV): analysis and statistics
Return, volatility, Sharpe ratio and risk for Solventum, an S&P 500 component in the Health Care sector. Data as of 2026-07-30.
| Last close price | $86.83 |
| Sector (GICS) | Health Care |
| Annualized return (0.0 yr) | +1676.73% |
| Total return over period | +9.56% |
| Annualized volatility | 47.88% |
| Sharpe ratio | 34.95 |
| Sortino ratio | 118.46 |
| Max drawdown | -1.94% |
| CVaR 95% (avg. loss, worst 5% of days) | -1.94% |
| Correlation with the S&P 500 | — |
| Period range | $77.24 – $88.55 |
| Trading days analyzed | 8 |
Over the last 0.0 years, Solventum (SOLV) has posted an annualized return of +1676.73% with annual volatility of 47.88%, a Sharpe ratio of 34.95. Its worst stretch (max drawdown from a peak) was -1.94%.
These are historical, realized metrics, not projections: they describe how the stock behaved, not how it will behave going forward. To see how SOLV would fit inside an optimized portfolio alongside other S&P 500 stocks, try the optimizer.
Optimize a portfolio with SOLV →
Other Health Care stocks
AAgilent TechnologiesABBVAbbVieABTAbbott LaboratoriesALGNAlign TechnologyAMGNAmgenAZNAstraZenecaBAXBaxter InternationalBDXBecton Dickinson
What is the Sharpe ratio? · How to optimize an S&P 500 portfolio
Information for educational purposes only. Not financial advice or a recommendation to buy or sell. Past performance does not guarantee future results.